Clinical trial
Phase 1/1b Study With Nab-sirolimus for Patients With Severe Pulmonary Arterial Hypertension
NCT02587325
Study timeline
Study start (actual)2017-04-01Date precision: day
Registry last updated2024-11-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Pulmonary Hypertensionunresolved
Interventions
nab-sirolimusDRUG
Sponsors & collaborators
Aadi Bioscience, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02587325 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.